Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Frye

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
ANZ Journal of Surgery|August 29, 2013
Accuracy of visual prediction of pathology of colorectal polyps: how accurate are we?Prashant Sharma, John Frye, Frank Frizelle
Cureus|January 3, 2022
Crisis Standards of Care Guidelines for the COVID-19 Pandemic: Fresno Resource Allocation Guide (FRAG)Patrick Macmillan, John Frye, Thianchai Bunnalai, et al.
International Journal of Pharmaceutical Compounding|July 11, 2020
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD CurriculaMohammad Faisal Hossain, Dan Levesque, John Frye, et al.
Leukemia Research|June 24, 2019
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myelomaParameswaran Hari, Claudia E Paba-Prada, Peter M Voorhees, et al.
The Journal of Clinical Ethics|October 2, 2019
Comprehensive Quality Assessment in Clinical EthicsThomas V Cunningham, Andrea Chatburn, Cynthia Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
ANZ Journal of Surgery|August 29, 2013
Accuracy of visual prediction of pathology of colorectal polyps: how accurate are we?Prashant Sharma, John Frye, Frank Frizelle
Cureus|January 3, 2022
Crisis Standards of Care Guidelines for the COVID-19 Pandemic: Fresno Resource Allocation Guide (FRAG)Patrick Macmillan, John Frye, Thianchai Bunnalai, et al.
International Journal of Pharmaceutical Compounding|July 11, 2020
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD CurriculaMohammad Faisal Hossain, Dan Levesque, John Frye, et al.
Leukemia Research|June 24, 2019
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myelomaParameswaran Hari, Claudia E Paba-Prada, Peter M Voorhees, et al.
The Journal of Clinical Ethics|October 2, 2019
Comprehensive Quality Assessment in Clinical EthicsThomas V Cunningham, Andrea Chatburn, Cynthia Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancerRazelle Kurzrock, Steven I Sherman, Douglas W Ball, et al.
Pageof 1